AGNPF (Grey Matters Health) Debt-to-EBITDA : (As of May. 2026)

Grey Matters Health  (OTCPK:AGNPF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Grey Matters Health Debt-to-EBITDA Related Terms

The historical data trend for Grey Matters Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Matters Health Debt-to-EBITDA Chart

Grey Matters Health Annual Data
	Trend	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24	Aug25
Debt-to-EBITDA		Get a 7-Day Free Trial					-	-	-	-	-

Grey Matters Health Quarterly Data
	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26	May26
Debt-to-EBITDA	Get a 7-Day Free Trial															-	-	-	-	-

AGNPF vs VRTX, REGN, MRNA: Debt-to-EBITDA Comparison

For the Biotechnology subindustry, Grey Matters Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grey Matters Health Debt-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Grey Matters Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Grey Matters Health's Debt-to-EBITDA falls into.

Grey Matters Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Grey Matters Health's Debt-to-EBITDA for the fiscal year that ended in Aug. 2025 is calculated as

Grey Matters Health's annualized Debt-to-EBITDA for the quarter that ended in May. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (May. 2026) EBITDA data.

Grey Matters Health Business Description